Probiotics prevent death caused by Citrobacter rodentium Infection in neonatal mice

Melanie Gareau, Eytan Wine, Colin Reardon, Philip M. Sherman

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background. Intestinal bacterial infections are a major cause of morbidity and mortality, especially in neonates. Therefore, the aims of this study were to characterize Citrobacter rodentium infection in neonatal mice and determine the role played by specific probiotics in ameliorating disease severity. Methods. Infection of C57BL/6 mice with C. rodentium was performed at postnatal day 14. A subset of mice was pretreated orally with either a mixture of Lactobacillus rhamnosus and Lactobacillus helveticus or placebo, starting at 7 days. To study the effects of B and T cells, rag1-/- and JH-/- mice were used, with survival, colonic crypt depth, and barrier function evaluated as outcome measures. Results. C. rodentium infection caused weight loss and death. In contrast, survival was maintained by daily treatment with Lactobacilli. Weight loss, colonic epithelial cell hyperplasia, mucosal barrier dysfunction, and elevated serum corticosterone levels in C. rodentium-infected wild-type mice were ameliorated by probiotics, but not in ragl-/- animals. Beneficial effects of probiotics were observed in B cell-deficient (JH -/-) mice, indicating the requirement of T cells in reducing the adverse sequelae of neonatal enteric infection. Conclusions. These findings demonstrate that C. rodentium infection in newborn mice causes death and that probiotics promote survival, but only in the presence of T cells.

Original languageEnglish (US)
Pages (from-to)81-91
Number of pages11
JournalJournal of Infectious Diseases
Volume201
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Citrobacter rodentium
Probiotics
Infection
T-Lymphocytes
Weight Loss
B-Lymphocytes
Lactobacillus helveticus
Lactobacillus rhamnosus
Lactobacillus
Corticosterone
Inbred C57BL Mouse
Bacterial Infections
Hyperplasia
Cause of Death
Epithelial Cells
Placebos
Outcome Assessment (Health Care)
Morbidity
Mortality
Serum

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Probiotics prevent death caused by Citrobacter rodentium Infection in neonatal mice. / Gareau, Melanie; Wine, Eytan; Reardon, Colin; Sherman, Philip M.

In: Journal of Infectious Diseases, Vol. 201, No. 1, 01.2010, p. 81-91.

Research output: Contribution to journalArticle

@article{7c75b7dec50a46dbb98441c44978e92e,
title = "Probiotics prevent death caused by Citrobacter rodentium Infection in neonatal mice",
abstract = "Background. Intestinal bacterial infections are a major cause of morbidity and mortality, especially in neonates. Therefore, the aims of this study were to characterize Citrobacter rodentium infection in neonatal mice and determine the role played by specific probiotics in ameliorating disease severity. Methods. Infection of C57BL/6 mice with C. rodentium was performed at postnatal day 14. A subset of mice was pretreated orally with either a mixture of Lactobacillus rhamnosus and Lactobacillus helveticus or placebo, starting at 7 days. To study the effects of B and T cells, rag1-/- and JH-/- mice were used, with survival, colonic crypt depth, and barrier function evaluated as outcome measures. Results. C. rodentium infection caused weight loss and death. In contrast, survival was maintained by daily treatment with Lactobacilli. Weight loss, colonic epithelial cell hyperplasia, mucosal barrier dysfunction, and elevated serum corticosterone levels in C. rodentium-infected wild-type mice were ameliorated by probiotics, but not in ragl-/- animals. Beneficial effects of probiotics were observed in B cell-deficient (JH -/-) mice, indicating the requirement of T cells in reducing the adverse sequelae of neonatal enteric infection. Conclusions. These findings demonstrate that C. rodentium infection in newborn mice causes death and that probiotics promote survival, but only in the presence of T cells.",
author = "Melanie Gareau and Eytan Wine and Colin Reardon and Sherman, {Philip M.}",
year = "2010",
month = "1",
doi = "10.1086/648614",
language = "English (US)",
volume = "201",
pages = "81--91",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Probiotics prevent death caused by Citrobacter rodentium Infection in neonatal mice

AU - Gareau, Melanie

AU - Wine, Eytan

AU - Reardon, Colin

AU - Sherman, Philip M.

PY - 2010/1

Y1 - 2010/1

N2 - Background. Intestinal bacterial infections are a major cause of morbidity and mortality, especially in neonates. Therefore, the aims of this study were to characterize Citrobacter rodentium infection in neonatal mice and determine the role played by specific probiotics in ameliorating disease severity. Methods. Infection of C57BL/6 mice with C. rodentium was performed at postnatal day 14. A subset of mice was pretreated orally with either a mixture of Lactobacillus rhamnosus and Lactobacillus helveticus or placebo, starting at 7 days. To study the effects of B and T cells, rag1-/- and JH-/- mice were used, with survival, colonic crypt depth, and barrier function evaluated as outcome measures. Results. C. rodentium infection caused weight loss and death. In contrast, survival was maintained by daily treatment with Lactobacilli. Weight loss, colonic epithelial cell hyperplasia, mucosal barrier dysfunction, and elevated serum corticosterone levels in C. rodentium-infected wild-type mice were ameliorated by probiotics, but not in ragl-/- animals. Beneficial effects of probiotics were observed in B cell-deficient (JH -/-) mice, indicating the requirement of T cells in reducing the adverse sequelae of neonatal enteric infection. Conclusions. These findings demonstrate that C. rodentium infection in newborn mice causes death and that probiotics promote survival, but only in the presence of T cells.

AB - Background. Intestinal bacterial infections are a major cause of morbidity and mortality, especially in neonates. Therefore, the aims of this study were to characterize Citrobacter rodentium infection in neonatal mice and determine the role played by specific probiotics in ameliorating disease severity. Methods. Infection of C57BL/6 mice with C. rodentium was performed at postnatal day 14. A subset of mice was pretreated orally with either a mixture of Lactobacillus rhamnosus and Lactobacillus helveticus or placebo, starting at 7 days. To study the effects of B and T cells, rag1-/- and JH-/- mice were used, with survival, colonic crypt depth, and barrier function evaluated as outcome measures. Results. C. rodentium infection caused weight loss and death. In contrast, survival was maintained by daily treatment with Lactobacilli. Weight loss, colonic epithelial cell hyperplasia, mucosal barrier dysfunction, and elevated serum corticosterone levels in C. rodentium-infected wild-type mice were ameliorated by probiotics, but not in ragl-/- animals. Beneficial effects of probiotics were observed in B cell-deficient (JH -/-) mice, indicating the requirement of T cells in reducing the adverse sequelae of neonatal enteric infection. Conclusions. These findings demonstrate that C. rodentium infection in newborn mice causes death and that probiotics promote survival, but only in the presence of T cells.

UR - http://www.scopus.com/inward/record.url?scp=71949129495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949129495&partnerID=8YFLogxK

U2 - 10.1086/648614

DO - 10.1086/648614

M3 - Article

C2 - 19961304

AN - SCOPUS:71949129495

VL - 201

SP - 81

EP - 91

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -